当前位置: 首页 > 详情页

Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, Austin, TX 78705 USA; [2]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [3]Montefiore Hosp, Albert Einstein Coll Med, New York, NY USA; [4]Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [5]Univ Foggia, Dept Cardiol, Foggia, Italy; [6]Osped Angelo, Mestre Venice, Italy; [7]Univ Cattolica Sacro Cuore, I-00168 Rome, Italy; [8]Calif Pacific Med Ctr, San Francisco, CA USA; [9]Dell Med Sch, Austin, TX USA; [10]St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, 3000 N I-35,Suite 720, Austin, TX 78705 USA
出处:
ISSN:

关键词: Atrial fibrillation Catheter ablation Pulmonary vein antrum isolation Left atrial posterior wall

摘要:
BACKGROUND It is unclear whether isolation of the Left atrial. posterior wall (LAPW) offers additional. benefits over pulmonary vein antrum isolation (PVAI) alone in patients with persistent atrial. fibrillation (AF). OBJECTIVE We sought to determine the impact of PVAI and LAPW isolation (PVAI+LAPW) versus PVAI alone on the outcome of ablation of persistent AF. METHODS During the first procedure, PVAI was performed in 20 patients (group 1), whereas in 32 patients (group 2), PVAI was extended to the Left atrial. (LA) septum and coronary sinus (CS), and isolation of the LAPW was targeted (ePVAI+LAPW). Isolation of the superior vena cava was achieved in both groups. ALL patients, regardless of arrhythmia recurrence, underwent a second procedure 3 months after the first procedure. In patients with reconnection of pulmonary veins or LAPW, reisolation was performed, and a third procedure was performed 3 months Later to verify isolation. Patients entered follow-up only after PVAI (group 1) or PVAI+LAPW (group 2) isolation was proven. RESULTS At the 1-, 2-, and 3-year follow-up examinations, the rates of freedom from atrial tachyarrhythmia without use of an antiarrhythmic drug were 20%, 15%, and 10% in group 1 and 65%, 50%, and 40% in group 2, respectively (Log-rank P < .001). The median recurrence-free survival. time was 8.5 months (interquartile range 6.5-11.0) in group 1 and 28.0 months (interquartile range 8.5-32.0) in group 2. CONCLUSION Proven isolation of the LAPW provides additional. benefits over PVAI alone in the treatment of persistent AF and improves procedural. outcome at follow-up. However, the ablation strategy of ePVAI+LAPW is still associated with a significant high incidence of very Late recurrence of atrial tachyarrhythmia.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 2 区 医学
小类 | 2 区 心脏和心血管系统
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 心脏和心血管系统
JCR分区:
出版当年[2014]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, Austin, TX 78705 USA; [2]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, Austin, TX 78705 USA; [8]Calif Pacific Med Ctr, San Francisco, CA USA; [9]Dell Med Sch, Austin, TX USA; [10]St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, 3000 N I-35,Suite 720, Austin, TX 78705 USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16399 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院